Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Wednesday, December 29, 2021

Non-Invasive Prenatal Testing Market is expected to grow at a CAGR of 13%-15% - An exclusive market research report by Lucintel

Lucintel's latest market report analyzed that non-invasive prenatal testing provides attractive opportunities in the personal care industry. The non-invasive prenatal testing market is expected to grow at a CAGR of 13%-15%. In this market, trisomy is the largest segment by application, whereas diagnostic laboratories are largest by end user.

Download Brochure of this report by clicking on https://www.lucintel.com/non-invasive-prenatal-testing-market.aspx

Based on application, the non-invasive prenatal testing market is segmented into trisomy, aneuploidy, and microdeletion. The trisomy segment is accounted for the largest share of the market in 2020 due to factors such as increasing maternal age and the rising incidence of chromosomal abnormalities.    

Browse in-depth TOC on “Non-Invasive Prenatal Testing Market”

XX – Tables

XX – Figures

150 – Pages

The non-invasive prenatal testing market is marked by the presence of several big and small players. Some of the prominent players offering non-invasive prenatal testing include Illumina, Thermo Fisher Scientific, GE Healthcare, BGI, Agilent Technologies, F. Hoffmann-La Roche, PerkinElmer, Laboratory Corporation of America Holdings, Natera, and Yourgene Health.

Request Sample Report:

https://www.lucintel.com/non-invasive-prenatal-testing-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: 
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Halal Ingredient Market:

For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx

 

GMO Testing Market:

For more details click here https://www.lucintel.com/gmo-testing-market.aspx

 

No comments:

Post a Comment